The Medicines Company Reports Third-Quarter 2017 Business and Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/26/2026
- Wall Street ends higher as investors buy AI stocks; Microsoft rallies
- Stock action shows confidence in central banks: BofA’s Hartnett
- Oil prices slide about 2% as US, Iran explore path out of war
- Why stocks held up despite rising yields and $100 oil? These 2 words explain it
- Barclays asks if equity markets are nearing the boiling point
- White House blocks CNN from Air Force One trip, Washington Post reports
- Merck and Daiichi Sankyo withdraw lung cancer drug application
- Exclusive-SK Hynix's Solidigm weighs IPO that could value the unit at up to $150 billion, sources say
- Wall Street ends higher as investors buy AI stocks; Microsoft rallies
- Fox Factory sells Marucci Sports for $225M, cuts debt
Medicines Co. (MDCO) Reports Q3 Loss Per Share of $1.19, Less Than Expected
October 25, 2017 7:10 AM EDTMedicines Co. (NASDAQ: MDCO) reported Q3 EPS of ($1.19), $0.25 better than the analyst estimate of ($1.44). Revenue for the quarter came in at $16.9 million versus the consensus estimate of $24.35 million.
For earnings history and earnings-related data on Medicines Co. (MDCO) click here.
... More